Medroxyprogesterone [Design Issues]

posted by Dr_Dan  – Germany, 2016-03-10 10:11 (3256 d 22:13 ago) – Posting: # 16084
Views: 5,076

Dear Ratnakar
The sampling schemes are more or less the same, WHO presents in days, FDA in hours. The only difference is a tighter sampling interval at day one in order to detect the initial peak suggested by the FDA and sampling twice per day for the first week suggested by WHO. I did a combination of both.
I hope this helps.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,667 registered users;
174 visitors (0 registered, 174 guests [including 10 identified bots]).
Forum time: 08:25 CET (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5